 |
||||||||
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
ADVENTRX Pharmaceuticals is a biopharmaceutical company focused on developing proprietary product candidates. The Company's lead product candidate is ANX-188, a rheologic, antithrombotic and cytoprotective agent that improves microvascular blood flow and has potential application in treating a wide range of diseases and conditions, such as complications arising from sickle cell disease. The Company also is developing ANX-514, a novel, detergent-free formulation of the chemotherapy drug docetaxel. ADVENTRX is based in San Diego, California. |